Magnus T. Dillon

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment

Magnus T. Dillon, Katharina Bergerhoff, Malin Pedersen et al. · Clinical Cancer Research · 2019 · 200 citations

Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei

Magnus T. Dillon, Holly E. Barker, Malin Pedersen et al. · Molecular Cancer Therapeutics · 2016 · 108 citations · Full text

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

Magnus T. Dillon, Z. Boylan, Deborah A. Smith et al. · Clinical and Translational Radiation Oncology · 2018 · 76 citations · Full text

Harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade

Emmanuel C. Patin, Magnus T. Dillon, Pablo Nenclares et al. · Journal for ImmunoTherapy of Cancer · 2022 · 66 citations · Full text

Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status

Hind Hafsi, Magnus T. Dillon, Holly E. Barker et al. · Frontiers in Oncology · 2018 · 48 citations · Full text